INFLUENCE OF TREATMENT WITH CLONIDINE ON CATECHOLAMINE SYNTHESIS IN HEART, SUBMAXILLARY-GLANDS AND ADRENAL-GLAND OF RAT

被引：14

作者：

BRALET, J ^{[1
]}

ROCHETTE, L ^{[1
]}

机构：

[1] FAC MED & PHARM DIJON,LABS PHYSIOL PHARM & PHARM DYN,BLVD JEANNE ARC,21000 DIJON,FRANCE

来源：

关键词：

D O I：

10.1016/0006-2952(73)90091-9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：3173 / 3180

页数：8

共 31 条

[21] SATTLER R. W., 1967, EUR J PHARMACOL, V2, P9, DOI 10.1016/0014-2999(67)90016-7
[22] CARDIOVASCULAR EFFECTS OF 2-(2,6-DICHLOROPHENYLAMINO)-2-IMIDAZOLINE HYDROCHLORIDE (ST 155) .2. CENTRAL SYMPATHETIC STRUCTURES
SCHMITT, H
SCHMITT, H
BOISSIER, JR
GIUDICELLI, JF
FICHELLE, J
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1968, 2 (05) : 340 - +
[23] LOCALIZATION OF HYPOTENSIVE EFFECT OF 2-(2-6-DICHLOROPHENYLAMINO)-2-IMIDAZOLINE HYDROCHLORIDE (ST-155 CATAPRESAN)
SCHMITT, H
SCHMITT, H
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1969, 6 (01) : 8 - &
[24] INHIBITION OF HORMONE-RELEASE FROM ADRENAL MEDULLA BY BAY-A-6781, AN ANTIHYPERTENSIVE AGENT
SCHUMANN, HJ
WERNER, U
[J]. NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE, 1971, 268 (01): : 71 - &
[25] SCRIABINE A, 1970, J PHARMACOL EXP THER, V171, P256
[26] EVIDENCE FOR A CENTRAL HYPOTENSIVE MECHANISM OF 2-(2,6-DICHLOROPHENYLAMINO)-2-IMIDAZOLINE (CATAPRESAN ST-155)
SHERMAN, GP
GREGA, GJ
WOODS, RJ
BUCKLEY, JP
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1968, 2 (04) : 326 - &
[27] STARKE K, 1972, ARCH INT PHARMACOD T, V195, P291
[28] WAALKES TP, 1957, J LAB CLIN MED, V50, P733
[29] WALDECK B, 1971, J PHARM PHARMACOL, V23, P64
[30] WEINER N, 1972, PHARMACOL REV, V24, P203